A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Northwestern University
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
University of Washington
M.D. Anderson Cancer Center
Northwestern University
Brown University
University of Rochester
Washington University School of Medicine
University of Utah
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Washington
City of Hope Medical Center
Hospices Civils de Lyon
Mayo Clinic
Shanghai Junshi Bioscience Co., Ltd.
Wake Forest University Health Sciences
Chinese PLA General Hospital
Roswell Park Cancer Institute
University of Chicago
Columbia University
The First Affiliated Hospital of Xiamen University
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
IRCCS San Raffaele
National University of Malaysia
Peter MacCallum Cancer Centre, Australia
Ruijin Hospital
Academic and Community Cancer Research United
Nanfang Hospital, Southern Medical University
Zhejiang Provincial People's Hospital
Prince of Wales Hospital, Shatin, Hong Kong
Institute of Hematology & Blood Diseases Hospital, China
Stichting Hemato-Oncologie voor Volwassenen Nederland
M.D. Anderson Cancer Center
Peking University Cancer Hospital & Institute
Mayo Clinic
M.D. Anderson Cancer Center
Ruijin Hospital
Sunnybrook Health Sciences Centre
Beijing Tongren Hospital
Masonic Cancer Center, University of Minnesota
GWT-TUD GmbH
Jewish General Hospital
The Affiliated Hospital of Xuzhou Medical University
The Affiliated Hospital of Xuzhou Medical University